Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 7,928

Document Document Title
WO/2012/013765A1
The invention relates to an enzymatic acylation method including at least the following steps of: contacting at least one compound having at least one function selected from among the amine, alcohol, or thiol functions, at least one micr...  
WO/2012/013016A1
The invention relates to the field of medicine. Curcumalactone derivatives with antitumor activity and the process for their preparation are disclosed. The said curcumalactone derivatives and their oxidized derivatives have a spironolact...  
WO/2012/007965A1
The present invention provides a process for production of optically pure quinuclidinol of formula-(I) by reduction of quinuclidinone of formula-(Il) in presence of suitable oxidoreductase enzyme derived from Saccharomyces species. Formu...  
WO/2012/007577A1
The buckwheat extract comprises a extract of buckwheat which are enriched in D-fagomine and including 3,4-di-epifagomine, a process for their preparation, pharmaceutical or veterinary compositions, dietary supplements or functional foods...  
WO/2012/007965A8
The present invention provides a process for production of optically pure quinuclidinol of formula-(I) by reduction of quinuclidinone of formula-(Il) in presence of suitable oxidoreductase enzyme derived from Saccharomyces species. Formu...  
WO/2011/160573A1
A method for producing rifamycin SV (Rf_SV) with high activity and high purity, and uses of cytochrome P450 gene or transketolase gene or the proteins encoded by the two genes in regulating the transformation of rifamycin SV into rifamyc...  
WO/2011/160484A1
Provided is a novel glycosyl hydrolase with beta-xylosidase and beta-glucosidase activities. The glycosyl hydrolase can convert the 7-xylosyl taxanes to 7-hydroxyl taxanes.  
WO/2011/159092A3
The present invention relates to the novel Rhizobium sp. GIN611 KCTC11708BP or to cell extracts thereof, to a novel oxidoreductase which exhibits a glycolytic activity, to a gene encoding the oxidoreductase, to a recombinant strain compr...  
WO/2011/159092A9
The present invention relates to the novel Rhizobium sp. GIN611 KCTC11708BP or to cell extracts thereof, to a novel oxidoreductase which exhibits a glycolytic activity, to a gene encoding the oxidoreductase, to a recombinant strain compr...  
WO/2011/159092A2
The present invention relates to the novel Rhizobium sp. GIN611 KCTC11708BP or to cell extracts thereof, to a novel oxidoreductase which exhibits a glycolytic activity, to a gene encoding the oxidoreductase, to a recombinant strain compr...  
WO/2011/159219A1
Disclosed is a process for production of a cycloaliphatic carbonate from a diol, triol or polyol and a carbon dioxide source, such as a dialkyl carbonate. Said process is performed in a solvent-free medium using a N-heterocyclic carbene ...  
WO/2011/149938A3
Processes for the synthesis of (3aS,7aR)-hexahydroisobenzofuran-1-(3H)-one, comprising comprising enzymatic hydrolysis of dimethyl cyclohexane-1,2-dicarboxylate to form (1S,2R)-2-(methoxycarbonyl) cyclohexanecarboxylic acid. The enzyme c...  
WO/2011/149938A2
Processes for the synthesis of (3aS,7aR)-hexahydroisobenzofuran-1-(3H)-one, comprising comprising enzymatic hydrolysis of dimethyl cyclohexane-1,2-dicarboxylate to form (1S,2R)-2-(methoxycarbonyl) cyclohexanecarboxylic acid. The enzyme c...  
WO/2011/140344A1
The invention relates to the production of flavonoids and flavonoid precursors in cells through recombinant expression of tyrosine ammonia lyase (TAL), 4-coumarate:CoA ligase (4CL), chalcone synthase (CHS), and chalcone isomerase (CHI).  
WO/2011/134355A1
The present invention discloses a preparation method and use of dihydrocanadensolide. The preparation method of the invention comprises the steps of solid fermentation, hydrolysis, separation and purification to obtain the natural dihydr...  
WO/2011/127589A1
Nucleic acid molecules encoding polypeptides having polyketide synthase activity have been identified and characterized. Expression or over-expression of the nucleic acids alters levels of cannabinoid compounds in organisms. The polypept...  
WO/2011/126382A1
A process for producing one or more organic chemical products or fuel from biomass, and in particular from microalgae, by means of high pressure hydrothermal treatment in the presence of metal oxide or metal-base catalysts.  
WO/2011/126082A1
An acyloxypyranone compound represented by formula (II) (wherein R1 represents an acyl group) is produced by causing an acylating agent and a hydrolase to act on hydroxypyranone represented by formula (I) in a hydrous organic solvent; an...  
WO/2011/126383A1
A process for producing one or more organic chemical products or fuel from microalgae or other lipid-containing biomass by means of high pressure hydrothermal treatment in the presence of clays and other aluminosilicates.  
WO/2011/121456A3
Sesquiterpene lactones (STLs) are characteristic natural products in Asteraceae, but the biochemistry and evolution of STLs in Asteraceae remain unexplored at the molecular level. The present invention relates to gene and protein sequenc...  
WO/2011/118887A1
The present invention relates to a novel method for preparing a pterocarpan from an isoflavan-4-ol. When the method of the present invention is used, the absolute configuration of the C3 and the C4 on the isoflavan-4-ol B-chain is mainta...  
WO/2011/118831A1
Disclosed is a manufacturing method for 5-(aminomethyl)-2-chlorothiazole including a reaction process in which an N-carbamoyl amino compound is reacted with a transformant culture acquired by introducing into an intracellular organism a ...  
WO/2011/118829A1
Disclosed is a manufacturing method and the like for an N-carbamoyl amino compound, including a reaction process wherein an enzyme, a microbe culture capable of producing the enzyme, or a processed product thereof, capable of transformin...  
WO/2011/118832A1
Disclosed is a manufacturing method and the like for 5-(aminomethyl)-2-chlorothiazol, including a reaction process wherein an enzyme, a microbe culture capable of producing the enzyme, or a processed product thereof, capable of transform...  
WO/2011/111738A1
Disclosed are substance FKI-4429-1 represented by formula [I] and three other substances. Filamentous bacteria having the capability of producing this substance FKI-4429-1 are cultured in a medium. The substance FKI-4429-1 accumulates in...  
WO/2011/110932A1
The present invention discloses a process for producing purple-blue natural pigment containing violacein and its derivative (deoxyviolacein) using Chromobacterium sp. NIIST-CKK-01 (MTCC 5522, NCIM 5341; Genbank Accession No. FJ982784). T...  
WO/2011/097720A1
The present disclosure provides an organosolv process. The present process comprises treating a lignocellulosic biomass in the presence of a solvent and under certain conditions to separate at least a part of the lignin from the biomass.  
WO/2011/093187A1
Disclosed is a method for producing a pyripyropene derivative represented by formula A using an enzymatic process. A pyripyropene derivative can be produced under simple conditions in a short procedure by the production method. (In the f...  
WO/2011/093186A1
Provided is a nucleic acid structure containing a pyripyropene biosynthesis gene cluster and a marker gene. Said nucleic acid structure allows pyripyropenes to be manufactured inexpensively with high productivity.  
WO/2011/091968A1
The invention relates to a method for producing racemic nebivolol of formula (I) from the enantiomer-pure compounds of formula (IVa) and (IVb), wherein racemic nebivolol is obtained by mixing enantiomer-pure d-nebivolol and I-nebivolol t...  
WO/2011/093185A1
Provided is a method for manufacturing a pyripyropene by culturing a microorganism, created by the introduction of a specific polynucleotide or a recombinant vector comprising same, together with an intermediate compound necessary for th...  
WO/2011/082365A3
Methods and systems for increasing the production of monatin in a multi-step equilibrium pathway are described. Tryptophan and pyruvate are added to a bioreactor to form a mixture comprising monatin and a plurality of intermediates via a...  
WO/2011/082365A2
Methods and systems for increasing the production of monatin in a multi-step equilibrium pathway are described. Tryptophan and pyruvate are added to a bioreactor to form a mixture comprising monatin and a plurality of intermediates via a...  
WO/2011/073956A2
This invention is related to bacterial engineering and the heterologous expression of useful compounds. In particular, the invention relates to a heterologous host that has been engineered for expression of a gene which is capable of pol...  
WO/2011/073956A3
This invention is related to bacterial engineering and the heterologous expression of useful compounds. In particular, the invention relates to a heterologous host that has been engineered for expression of a gene which is capable of pol...  
WO/2011/072287A3
The presently disclosed subject matter demonstrates that ThnG and ThnQ enzymes encoded by the thienamycin gene cluster in Streptomyces cattleya oxidize the C-2 and C-6 moieties of carbapenems, respectively. ThnQ stereospecifically hydrox...  
WO/2011/072287A2
The presently disclosed subject matter demonstrates that ThnG and ThnQ enzymes encoded by the thienamycin gene cluster in Streptomyces cattleya oxidize the C-2 and C-6 moieties of carbapenems, respectively. ThnQ stereospecifically hydrox...  
WO/2011/071396A1
Antifungal compounds, an antifungal compound extracted from Epicoccum purpurascens, also known as Epicoccum nigrum, methods of producing the antifungal compounds, isolates and compositions comprising the antifungal compounds, and methods...  
WO/2011/058446A3
The present invention relates to gene and protein sequences for a thebaine 6-O- demethylase from Papaver somniferum and methods of use therefor. The present invention also relates to gene and protein sequences for a codeine O-demethylase...  
WO/2011/057126A1
The invention provides compounds of formula (I) wherein u, d, v, m, n, R1, W, X, Y, and Z have any values defined herein, as well as salts thereof. The compounds have activity as anti-proliferative agents.  
WO/2011/054929A2
The invention relates to a method for producing triptolide from a suspension cell culture of Tripterygium sp., to a triptolide-enriched extract obtainable by means of extraction from the culture medium of an in vitro culture of dediffere...  
WO/2011/054929A3
The invention relates to a method for producing triptolide from a suspension cell culture of Tripterygium sp., to a triptolide-enriched extract obtainable by means of extraction from the culture medium of an in vitro culture of dediffere...  
WO/2011/048583A1
The present invention relates to a process for the preparation of mono-para- nitrobenzyl malonate Formula (II) or its salt.  
WO/2011/039268A1
A sustainable biosynthesizing of tetrodotoxin (TTX) based on seed culture of Vibrio spp is obtained from the mucus of various species of nemerteans (ribbon worms) (phylum Nemertea). The indispensable organisms are kept alive which extend...  
WO/2011/034217A1
Provided is a novel bioactive substance produced from tea leaves. A novel polyphenol derivative is produced by extraction of microorganism-fermented tea leaves obtained by culturing Aspergillus sp. (PK-1) bacteria using tea leaves.  
WO/2011/024711A1
A novel compound represented by general formula (1) and salts thereof, which are obtained by subjecting amycolamicin obtained from a microorganism belonging to the genus Amycolatopsis or a salt thereof to decomposition under acid conditi...  
WO/2011/021036A1
The invention relates to compounds of formula (I) wherein the variables are as defined in the description and their use in therapy.  
WO/2011/016102A1
The object aims to improve the durability of the enzymatic properties of formate dehydrogenase. The object can be achieved by utilizing a particular type of formate dehydrogenase which has a specific activity too high to be predicted fro...  
WO/2011/016351A1
The purpose of the present invention is to find compounds having a DNA synthase inhibitory effect and provide novel medicinal compositions (DNA synthase inhibitors, anticancer agents and antiinflammatory agents) using said compounds. Dis...  
WO/2011/011464A2
Improved constructs for increasing efficiency of transformation of thermophilic host cells for production of carbon-based products of interest and methods for producing carbon- based products of interest are provided.  

Matches 151 - 200 out of 7,928